Skip to main content Accessibility help

Current Concepts in the Neuropathology and Pathogenesis of Multiple Sclerosis

  • G.R. Wayne Moore (a1)


Multiple sclerosis (MS) has been classically regarded as an inflammatory demyelinating disease of the central nervous system. In recent years, the classification and pathogenesis of the disease have become controversial, particularly with respect to whether an individual patient demonstrates a single or multiple pathogenetic mechanisms in the establishment of the focal plaque of MS. It is also becoming increasingly apparent that there is a significant neurodegenerative component in the disease, involving not only plaques but the non-plaque parenchyma as well. Magnetic resonance imaging, together with histopathologic studies, will continue to shed light on the pathogenesis of these focal and diffuse abnormalities in MS.


La sclérose en plaques (SP) est considérée comme une maladie démyélinisante inflammatoire du système nerveux central. Au cours des dernières années, la classification et la pathogenèse de la maladie ont fait l'objet de controverses, particulièrement en ce qui concerne la présence d'un ou de plusieurs mécanismes pathogènes dans la formation de la plaque focale de la SP. Il est de plus en plus évident qu'il existe une composante neurodégénérative significative dans cette maladie, impliquant non seulement les plaques mais aussi le parenchyme exempt de plaques. L'IRM a contribué et, conjointement avec les études anatomopathologiques, continuera à élucider la pathogenèse de ces anomalies focales et diffuses dans la SP.

    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Current Concepts in the Neuropathology and Pathogenesis of Multiple Sclerosis
      Available formats

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Current Concepts in the Neuropathology and Pathogenesis of Multiple Sclerosis
      Available formats

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Current Concepts in the Neuropathology and Pathogenesis of Multiple Sclerosis
      Available formats


Corresponding author

Room 5450, Blusson Spinal Cord Centre, ICORD (International Collaboration on Repair Discoveries), 818 West 10th Avenue, Vancouver, British Columbia, V5Z 1M9, Canada.


Hide All
1. Carswell, R. Pathological anatomy. Ilustrations of the elementary forms of disease. London: Longman, Orme, Brown, Green and Longman; 1838.
2. Cruveilhier, J. Anatomie pathologique du corps humain; descriptions avec figures lithographieεs et coloriees; des diverses alterations morbides dont le corps humain est susceptible. Paris: JB Balliere; 18291842.
3. Dawson, JW. The histology of multiple sclerosis. Trans R Soc Edin Reproduced by the Montreal Neurological Institute, Montreal, 1973. 1916;50:517–40 (with plates).
4. Compston, A, Lassmann, H, McDonald, WI. The story of multiple sclerosis. In: Compston, A, Confavreux, C, Lassmann, H, et al, Editors. McAlpine’s multiple sclerosis, 4th edition. Philadelphia: Churchill Livingstone Elsevier; 2006. p. 368.
5. Lassman, H, Wekerle, H. The pathology of multiple sclerosis. In: Compston, A, Confavreux, C, Lassman, H, et al, Editors. McAlpine’s multiple sclerosis, 4th edition. Philadelphia: Churchill Livingstone Elsevier; 2006. p. 557–99.
6. Sobel, RA, Moore, GRW. Demyelinating diseases. In: Love, S, Louis, DN, Ellison, DW, Editors. London: Hodder Arnold; 2008. p. 1513–608.
7. Ludwin, SK, Raine, CS. The neuropathology of multiple sclerosis. In: Raine, CS, McFarland, HF, Hohlfeld, R, editors. Multiple SclerosisAcomprehensive text. Philadelphia: Saunders Elsevier; 2008. p. 151–7.
8. Prineas, JW, Connell, F. The fine structure of chronically active multiple sclerosis plaques. Neurology. 1978;28(9 (Part 2)): 6875.
9. Lampert, PW. Fine stucture of the demyelinating process. In: Hallpike, JF, Adams, CWM, Tourtellotte, WW, editors. Multiple sclerosis: pathology, diagnosis and management. Baltimore: Williams and Wilkins; 1983. p. 2946.
10. Frohman, EM, Racke, MK, Raine, CS. Multiple sclerosis--the plaque and its pathogenesis. N Engl J Med. 2006 Mar 2;354(9):942–55.
11. Raine, CS, Scheinberg, L, Waltz, JM. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Lab Invest. 1981 Dec;45(6):534–46.
12. Franklin, RJ, Ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci. 2008 Nov;9(11):839–55.
13. Prineas, JW, Kwon, EE, Cho, ES, et al. Continual breakdown and regeneration of myelin in progressive multiple sclerosis plaques. Ann N Y Acad Sci. 1984;436:1132.
14. Ferguson, B, Matyszak, MK, Esiri, MM, et al. Axonal damage in acute multiple sclerosis lesions. Brain. 1997 Mar;120 (Pt 3): 393–9.
15. Trapp, BD, Peterson, J, Ransohoff, RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998 Jan 29;338 (5):278–85.
16. Raine, CS. Demyelinating Disease. In Textbook of Neuropathology. 3rd Edition. Baltimore:Williams & Wilkins, pp 627714. 3rd ed. Baltimore: Williams & Wilkins 1997.
17. Marburg, O. Die sogenannte “akute multiple sklerose” (Encephalomyelitis periaxialis scleroticans). Jahrbucher fur Psychiatrie und Neurologie. 1906;27:213312.
18. Moore, GRW. Neuropathology and pathophysiology of the multiple sclerosis lesion. In: Paty, DW, Ebers, GC, editors. Multiple sclerosis. Philadelphia: F.A. Davis; 1998. p. 257327.
19. Prineas, JW. The neuropathology of multiple sclerosis. In: Koetsier, JC, editor. Handbook of clinical neurology, Volume 3 (47). Amsterdam: Elsevier; 1985. p. 213–57.
20. Prineas, JW. Pathology of multiple sclerosis. In: Cook, SD, editor. Handbook of multiple sclerosis. New York: Marcel Decker; 1990. p. 187218.
21. Prineas, JW, Wright, RG. Macrophages, lymphocytes and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest. 1978(38):409–21.
22. Prineas, JW, Barnard, RO, Revesz, T, et al. Multiple sclerosis. Pathology of recurrent lesions. Brain. 1993 Jun;116 (Pt 3): 681–93.
23. Sanders, V, Conrad, AJ, Tourtellotte, WW. On classification of postmortem multiple sclerosis plaques for neuroscientists. J Neuroimmunol. 1993 Jul;46(1–2):207–16.
24. Bo, L, Mork, S, Kong, PA, et al. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol. 1994 May;51(2):135–46.
25. Lucchinetti, C, Bruck, W, Parisi, J, et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000 Jun;47(6):707–17.
26. Lucchinetti, CF, Parisi, J, Bruck, W. The pathology of multiple sclerosis. Neurol Clin. 2005 Feb;23(1):77105, vi.
27. Keegan, M, Konig, F, McClelland, R, et al. Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet. 2005 Aug 13–19;366 (9485):579–82.
28. Bruck, W, Neubert, K, Berger, T, et al. Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination--possible markers for an antibody-mediated process. Mult Scler. 2001 Jun;7(3):173–7.
29. Mahad, D, Ziabreva, I, Lassmann, H, et al. Mitochondrial defects in acute multiple sclerosis lesions. Brain. 2008 Jul;131(Pt 7): 1722–35.
30. Stadelmann, C, Ludwin, S, Tabira, T, et al. Tissue preconditioning may explain concentric lesions in Balo’s type of multiple sclerosis. Brain. 2005 May;128(Pt 5):979–87.
31. Barnett, MH, Prineas, JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol. 2004 Apr;55(4):458–68.
32. Lucchinetti, CF, Bruck, W, Lassmann, H. Evidence for pathogenic heterogeneity in multiple sclerosis (letter). Ann Neurol. 2004;56 (2):308.
33. Pender, MP. Oliogodendrocyte apopotosis before immune attack in multiple sclerosis? (letter). Ann Neurol 2005;57(1):158.
34. Prineas, JW, Barnett, MH. Reply (letter). Ann Neurol. 2005;57 (158159).
35. Barnett, MH, Parratt, JD, Cho, ES, et al. Immunoglobulins and complement in postmortem multiple sclerosis tissue. Ann Neurol. 2009 Jan;65(1):3246.
36. Breij, EC, Brink, BP, Veerhuis, R, et al. Homogeneity of active demyelinating lesions in established multiple sclerosis. Ann Neurol. 2008 Jan;63(1):1625.
37. Raine, CS. Multiple sclerosis: classification revisited reveals homogeneity and recapitulation. Ann Neurol. 2008 Jan;63(1): 13.
38. Esiri, MM. MS: is it one disease? Int MS J. 2009 Jun;16(2):3941.
39. Stewart, WA, Hall, LD, Berry, K, et al. Correlation between NMR scan and brain slice data in multiple sclerosis. Lancet. 1984 (ii):412.
40. Paty, DW, Moore, GRW. Magnetic resonance imaging changes as living pathology in multiple sclerosis In: Paty, DW, Ebers, GC, editors. Multiple Sclerosis. Philadelphia: F.A. Davis; 1998. p. 328–69.
41. Moore, GR. MRI-clinical correlations: more than inflammation alone-what can MRI contribute to improve the understanding of pathological processes in MS? J Neurol Sci. 2003 Feb 15;206(2): 175–9.
42. van Walderveen, MA, Kamphorst, W, Scheltens, P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology. 1998 May;50 (5):1282–8.
43. Bitsch, A, Kuhlmann, T, Stadelmann, C, et al. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol. 2001 Jun;49(6):793–6.
44. Katz, D, Taubenberger, JK, Cannella, B, et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol. 1993 Nov;34(5): 661–9.
45. Ludwin, SK, Henry, JM, McFarland, HF. Vascular proliferation and angiogenesis in MS: clinical and pathogenetic implications (abstract). J Neuropathol Exp Neurol. 2001;60:505.
46. Sajja, BR, Wolinsky, JS, Narayana, PA. Proton magnetic resonance spectroscopy in multiple sclerosis. Neuroimaging Clin N Am. 2009 Feb;19(1):4558.
47. Bjartmar, C, Battistuta, J, Terada, N, et al. N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol. 2002 Jan;51(1):51–8.
48. Arnold, DL, Matthews, PM, Francis, GS, et al. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol. 1992 Mar;31(3):235–41.
49. Narayana, PA, Doyle, TJ, Lai, D, et al. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multipl sclerosis. Ann Neurol. 1998 Jan;43(1):5671.
50. Bitsch, A, Bruhn, H, Vougioukas, V, et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol. 1999 Oct;20(9):1619–27.
51. Brex, PA, Parker, GJ, Leary, SM, et al. Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations. J Neurol Neurosurg Psychiatry. 2000 May;68(5): 627–32.
52. Helms, G, Stawiarz, L, Kivisakk, P, et al. Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions. Magn Reson Med. 2000 Jan;43(1):102–10.
53. Husted, CA, Goodin, DS, Hugg, JW, et al. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging. Ann Neurol. 1994 Aug;36(2):157–65.
54. Schmierer, K, Scaravilli, F, Altmann, DR, et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol. 2004 Sep;56(3):407–15.
55. Schmierer, K, Wheeler-Kingshott, CA, Tozer, DJ, et al. Quantitative magnetic resonance of postmortem multiple sclerosis brain before and after fixation. Magn Reson Med. 2008 Feb;59(2): 268–77.
56. van Waesberghe, JH, Kamphorst, W, De Groot, CJ, et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol. 1999 Nov;46 (5):747–54.
57. Fisher, E, Chang, A, Fox, RJ, et al. Imaging correlates of axonal swelling in chronic multiple sclerosis brains. Ann Neurol. 2007 Sep;62(3):219–28.
58. Rovaris, M, Gass, A, Bammer, R, et al. Diffusion MRI in multiple sclerosis. Neurology. 2005 Nov 22;65(10):1526–32.
59. Schmierer, K, Wheeler-Kingshott, CA, Boulby, PA, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain. Neuroimage. 2007 Apr 1;35(2):467–77.
60. MacKay, A, Whittall, K, Adler, J, et al. In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med. 1994 Jun;31(6):673–7.
61. Moore, GR, Leung, E, MacKay, AL, et al. A pathology-MRI study of the short-T2 component in formalin-fixed multiple sclerosis brain. Neurology. 2000 Nov 28;55(10):1506–10.
62. Laule, C, Leung, E, Lis, DK, et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult Scler. 2006 Dec;12(6):747–53.
63. Vavasour, IM, Laule, C, Li, DK, et al. Longitudinal changes in myelin water fraction in two MS patients with active disease. J Neurol Sci. 2009 Jan 15;276(1–2):4953.
64. Nesbit, GM, Forbes, GS, Scheithauer, BW, et al. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology. 1991 Aug;180(2): 467–74.
65. Bruck, W, Bitsch, A, Kolenda, H, et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol. 1997 Nov; 42(5):783–93.
66. Karaarslan, E, Altintas, A, Senol, U, et al. Balo’s concentric sclerosis: clinical and radiologic features of five cases. AJNR Am J Neuroradiol. 2001 Aug;22(7):1362–7.
67. Kidd, D, Barkhof, F, McConnell, R, et al. Cortical lesions in multiple sclerosis. Brain. 1999 Jan;122 (Pt 1):1726.
68. Geurts, JJ, Bo, L, Pouwels, PJ, et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol. 2005 Mar;26(3):572–7.
69. Peterson, JW, Bo, L, Mork, S, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001 Sep;50(3):389400.
70. Roosendaal, SD, Moraal, B, Pouwels, PJ, et al. Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler. 2009 Jun;15(6):708–14.
71. Kutzelnigg, A, Lassmann, H. Cortical demyelination in multiple sclerosis: a substrate for cognitive deficits? J Neurol Sci. 2006 Jun 15;245(1–2):123–6.
72. Wegner, C, Esiri, MM, Chance, SA, et al. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology. 2006 Sep 26;67(6):960–7.
73. Bo, L, Vedeler, CA, Nyland, H, et al. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler. 2003 Aug;9(4):323–31.
74. Bo, L, Vedeler, CA, Nyland, HI, et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol. 2003 Jul;62(7):723–32.
75. Roemer, S, Stadelmann, C, Bruck, W, et al. Cortical demyelination is present in early multiple sclerosis (abstract). Neurology. 2006 March;66 (Suppl 2)(5):A93–4.
76. Kangarlu, A, Bourekas, EC, Ray-Chaudhury, A, et al. Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. AJNR Am J Neuroradiol. 2007 Feb;28(2):262–6.
77. Huitinga, I, De Groot, CJ, Van der Valk, P, et al. Hypothalamic lesions in multiple sclerosis. J Neuropathol Exp Neurol. 2001 Dec;60 (12):1208–18.
78. Vercellino, M, Masera, S, Lorenzatti, M, et al. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol. 2009 May;68(5): 489502.
79. Allen, IV, Glover, G, Anderson, R. Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis (MS). Acta Neuropathol Suppl (Berl). 1981;7: 176–8.
80. Allen, IV, McKeown, SR. A histological, histochemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci. 1979 Mar;41(1):8191.
81. Kutzelnigg, A, Lucchinetti, CF, Stadelmann, C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005 Nov;128(Pt 11):2705–12.
82. Allen, IV, McQuaid, S, Mirakhur, M, et al. Pathological abnormalities in the normal-appearing white matter in multiple sclerosis. Neurol Sci. 2001 Apr;22(2):141–4.
83. Gobin, SJ, Montagne, L, Van Zutphen, M, et al. Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions. Glia. 2001 Oct;36(1):6877.
84. Arstila, AU, Riekkinen, P, Rinne, UK, et al. Studies on the pathogenesis of multiple sclerosis. Participation of lysosomes on demyelination in the central nervous system white matter outside plaques. Eur Neurol. 1973;9(1):120.
85. Riekkinen, PJ, Rinne, UK, Arstila, AU. Neurochemical and morphological studies on demyelination in multiple sclerosis with special reference to etiological aspects. Z Neurol. 1972;203(2):91104.
86. Rinne, UK, Riekkinen, PJ, Arstila, AU. Biochemical and electron microscopic alterations in the white matter outside demyelinated plaques in multiple sclerosis. . In: Lubowitz, U, editor. Progress in Multiple Sclerosis. New York: Academic Press; 1972. p. 7698.
87. Lindberg, RL, De Groot, CJ, Montagne, L, et al. The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis. Brain. 2001 Sep;124(Pt 9):1743–53.
88. Sobel, RA, Ahmed, AS. White matter extracellular matrix chondroitin sulfate/dermatan sulfate proteoglycans in multiple sclerosis. J Neuropathol Exp Neurol. 2001 Dec;60(12): 1198–207.
89. Plumb, J, McQuaid, S, Mirakhur, M, Kirk, J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 2002 Apr;12(2): 154–69.
90. Kirk, J, Plumb, J, Mirakhur, M, et al. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol. 2003 Oct;201(2):319–27.
91. Evangelou, N, Esiri, MM, Smith, S, et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol. 2000 Mar;47(3):391–5.
92. Evangelou, N, Konz, D, Esiri, MM, et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain. 2000 Sep; 123 (Pt 9):1845–9.
93. De Stefano, N, Narayanan, S, Francis, SJ, et al. Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch Neurol. 2002 Oct;59(10): 1565–71.
94. Miller, DH, Thompson, AJ, Filippi, M. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol. 2003 Dec;250(12): 1407–19.
95. Narayana, PA, Wolinsky, JS, Rao, SB, et al. Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis. Mult Scler. 2004 Jun;10 Suppl 1:S73–8.
96. Inglese, M, Li, BS, Rusinek, H, et al. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn Reson Med. 2003 Jul;50(1):190–5.
97. Fernando, KT, McLean, MA, Chard, DT, et al. Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. Brain. 2004 Jun;127(Pt 6):1361–9.
98. Ropele, S, Fazekas, F. Magnetization transfer MR imaging in multiple sclerosis. Neuroimaging Clin N Am. 2009 Feb;19(1): 2736.
99. Werring, DJ, Clark, CA, Droogan, AG, et al. Water diffusion is elevated in widespread regions of normal-appearing white matter in multiple sclerosis and correlates with diffusion in focal lesions. Mult Scler. 2001 Apr;7(2):83–9.
100. Guo, AC, Jewells, VL, Provenzale, JM. Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging. AJNR Am J Neuroradiol. 2001 Nov-Dec;22(10):1893–900.
101. van Walderveen, MA, van Schijndel, RA, Pouwels, PJ, et al. Multislice T1 relaxation time measurements in the brain using IR-EPI: reproducibility, normal values, and histogram analysis in patients with multiple sclerosis. J Magn Reson Imaging. 2003 Dec;18(6):656–64.
102. Traboulsee, A, Dehmeshki, J, Peters, KR, et al. Disability in multiple sclerosis is related to normal appearing brain tissue MTR histogram abnormalities. Mult Scler. 2003 Dec;9(6):566–73.
103. Bakshi, R, Benedict, RH, Bermel, RA, et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol. 2002 Jan;59(1):62–8.
104. Cifelli, A, Arridge, M, Jezzard, P, et al. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol. 2002 Nov;52(5):650–3.
105. Zhao, GJ, Li, DKB, Cheng, Y, et al. MRI dirty-appearing white matter in MS (abstract). Neurology. 2000;54 (suppl 3):A121.
106. Seewann, A, Vrenken, H, van der Valk, P, et al. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch Neurol. 2009 May;66(5):601–9.
107. Vos, CM, Geurts, JJ, Montagne, L, et al. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis. 2005 Dec; 20(3):953–60.
108. Segarra, JM. Histological and histochemical staining methods: A selection In: Teduchi, CG, editor. Neuropathology Methods and Diagnosis. Boston: Little, Brown and Company; 1970. p. 233–69.
109. Moore, GR, Laule, C, Mackay, A, et al. Dirty-appearing white matter in multiple sclerosis: preliminary observations of myelin phospholipid and axonal loss. J Neurol. 2008 Nov;255(11):1802–11, discussion 12.
110. Laule, C, Kozlowski, P, Leung, E, et al. Myelin water imaging of multiple sclerosis at 7 T: correlations with histopathology. Neuroimage. 2008 May 1;40(4):1575–80.
111. Filippi, M, Rocca, MA, Martino, G, et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol. 1998 Jun;43(6):809–14.
112. Laule, C, Vavasour, IM, Whittall, KP, et al. Evolution of focal and diffuse magnetisation transfer abnormalities in multiple sclerosis. J Neurol. 2003 Aug;250(8):924–31.
113. Wuerfel, J, Bellmann-Strobl, J, Brunecker, P, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain. 2004 Jan; 127(Pt 1):111–9.
114. Werring, DJ, Brassat, D, Droogan, AG, et al. The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. Brain. 2000 Aug;123 (Pt 8):1667–76.
115. Tartaglia, MC, Narayanan, S, De Stefano, N, et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol. 2002 Oct;249(10):1382–90.

Current Concepts in the Neuropathology and Pathogenesis of Multiple Sclerosis

  • G.R. Wayne Moore (a1)


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed